Literature DB >> 7163352

Morphine analgesia and tolerance in the tail-flick and formalin tests: dose-response relationships.

F V Abbott, R Melzack, B F Leber.   

Abstract

The dose-response relationships for morphine analgesia were studied in morphine-tolerant and non-tolerant rats using two pain tests: the tail-flick test which measures the threshold for an escape response, and the formalin test which assesses the behavioral response to continuous pain generated in injured tissue. The effects of prior experience with both pain tests on tolerance were also examined. In the formalin test, effective analgesia was obtained in non-tolerant rats at doses that produce minimal depression of locomotor behavior. Morphine tolerance was produced by 20 daily injections of morphine with increments that reached 16 mg/kg, a dose over the LD100 for barrier sustained Long Evans rats. This dose regimen produced a 1.8-fold increase in the ED50 in the tail-flick test and a 2.7-fold increase in the formalin test. Daily experience of the pain test, as well as the morphine regimen produced a 4.8-fold increase in the ED50 in the tail-flick test but did not affect the potency of morphine in the formalin test. The magnitude of tolerance in the absence of daily behavioral testing is consistent with recent clinical reports that little tolerance occurs after prolonged administration of morphine in cancer patients and that tolerance is not an important consideration in the management of pain.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7163352     DOI: 10.1016/0091-3057(82)90123-x

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  6 in total

Review 1.  Paradoxical signal transduction in neurobiological systems.

Authors:  F C Colpaert; Y Frégnac
Journal:  Mol Neurobiol       Date:  2001 Aug-Dec       Impact factor: 5.590

2.  Tolerance to morphine analgesia is reduced by the novel addition or omission of an alcohol cue.

Authors:  C X Poulos; T Hunt; H Cappell
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

3.  Baclofen administration alters fear extinction and GABAergic protein levels.

Authors:  Chelcie F Heaney; Monica M Bolton; Andrew S Murtishaw; Jonathan J Sabbagh; Christy M Magcalas; Jefferson W Kinney
Journal:  Neurobiol Learn Mem       Date:  2012-09-23       Impact factor: 2.877

4.  Antinociceptive effect of intracerebroventricular administration of D-serine on formalin-induced pain.

Authors:  Miho Ito; Masanobu Yoshikawa; Kenji Ito; Mitsumasa Matsuda; Xing Lu Jin; Shigeru Takahashi; Hiroyuki Kobayashi; Toshiyasu Suzuki
Journal:  J Anesth       Date:  2013-09-19       Impact factor: 2.078

5.  Comparison of morphine, oxycodone and the biased MOR agonist SR-17018 for tolerance and efficacy in mouse models of pain.

Authors:  Fani Pantouli; Travis W Grim; Cullen L Schmid; Agnes Acevedo-Canabal; Nicole M Kennedy; Michael D Cameron; Thomas D Bannister; Laura M Bohn
Journal:  Neuropharmacology       Date:  2020-12-17       Impact factor: 5.250

6.  Nicotinic modulation of descending pain control circuitry.

Authors:  Iboro C Umana; Claire A Daniele; Brooke A Miller; Chandrika Abburi; Keith Gallagher; Meghan A Brown; Peggy Mason; Daniel S McGehee
Journal:  Pain       Date:  2017-10       Impact factor: 7.926

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.